Filing Details
- Accession Number:
- 0001110803-14-000388
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-02 17:35:29
- Reporting Period:
- 2014-12-01
- Filing Date:
- 2014-12-02
- Accepted Time:
- 2014-12-02 17:35:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1441876 | Mostafa Ronaghi | 5200 Illumina Way San Diego CA 92122 | Sr Vp & Cto | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-12-01 | 10,000 | $44.38 | 38,604 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-12-01 | 2,160 | $187.53 | 36,444 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-01 | 5,178 | $188.39 | 31,266 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-01 | 2,537 | $189.29 | 28,729 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-01 | 125 | $190.89 | 28,604 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-12-01 | 10,000 | $0.00 | 10,000 | $44.38 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | 2009-08-04 | 2018-08-04 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 2,160 shares sold ranging from $186.97 to $187.94 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 5,178 shares sold ranging from $187.97 to $188.89 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 2,537 shares sold ranging from $189.00 to $189.99 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
